Perpetua Medical AB (publ) (OM:PERP B) signed a letter of intent to acquire 70% stake in Es-Medical Ab for SEK 5.2 million on June 18, 2024. The transaction is intended to be made at an initial purchase price of SEK 5.23 million, divided into an investment through a directed share issue of SEK 2.09 million and acquisition of shares of SEK 3.14 million from the Company?s current shareholders. Three years after the initial investment, Perpetua Medical has an option to acquire the remaining 30% of the shares in ES-Medical at a predetermined multiple. Furthermore, two earn-outs may be paid over two years, corresponding to 20% of the Company?s operating profit before depreciation and amortization for each year. The earn-out period is expected to commence in 2028 at the earliest. The company has an option to acquire the remaining 30% after three years. The transaction is conditional on Perpetua Medical?s due diligence and that the parties agree to enter into a share purchase agreement. The signing of the share purchase agreement is scheduled for Q3 2024.

Mangold Fondkommission AB acted as Financial Advisor to Perpetua Medical.